Spencer Nam
Founder at KSV Global
Net worth: 242 $ as of 2023-12-30
Network origin in Spencer Nam first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 21 | |
KSV Global
 KSV Global Investment ManagersFinance KSV Global Innovations LP provides investment services. The company was founded by Dan Gay, Jon Gay, Ted Jeong, and Spencer Nam in 2018 and is headquartered in Boston, MA.
5
| Private Company | Investment Managers | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Spencer Nam via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Idun Pharmaceuticals, Inc.
 Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member | |
| SYNDAX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Chief Executive Officer Director of Finance/CFO | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Chief Operating Officer | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
| BIOMÉRIEUX | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| Pohang University of Science & Technology | College/University | Graduate Degree Graduate Degree | |
| Babson College | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| The Johns Hopkins University | College/University | Graduate Degree Graduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
| University of Maryland | College/University | Doctorate Degree Masters Business Admin | |
| Utah State University | College/University | Undergraduate Degree Undergraduate Degree | |
Qualicaps, Inc.
 Qualicaps, Inc. Medical DistributorsDistribution Services Qualicaps, Inc. supplies capsule manufacturing equipment. It offers capsules equipment accessories, such as gelatin, nutritional, minicapsules, capsules filling equipment, and sealing equipment. The company also provides services like new product design, technical service, color formulation, capsule printing, and capsule samples. Qualicaps was founded in 1965 and is headquartered in Whitsett, NC. | Medical Distributors | Corporate Officer/Principal | |
Hyundai Venture Investment Corp.
 Hyundai Venture Investment Corp. Investment ManagersFinance Hyundai Venture Investment Corp. (HVIC) is the venture capital arm of Hyundai Finance Corp., founded in 1997. The firm is headquartered in Seoul, South Korea. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
HGGC LLC
 HGGC LLC Investment ManagersFinance HGGC LLC (HGGC) is a private equity firm founded in 2007 by Robert Gay, Greg Benson, Rich Lawson and Steve Young. The firm is headquartered in Palo Alto, California and was formerly known as Huntsman Gay Global Capital LLC. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Medical/Nursing Services | Director/Board Member | |
Kensington Capital Ventures LLC
 Kensington Capital Ventures LLC Investment ManagersFinance Kensington Capital Ventures LLC (Kensington Capital) is a private equity/venture capital subsidiary of Kensington Capital Holdings, LLC founded in 2008 by Alison H. Mosca. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| East Durham College | College/University | Undergraduate Degree | |
Deerfield Management Co. LP (Private Equity)
 Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Investment Managers | Private Equity Investor | |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Blade Therapeutics, Inc. offers anti-fibrotic therapies to meet unserved patient needs. Its product portfolio is to address various fibrotic diseases and their underlying pathophysiology. The company was founded by Hal Dietz and Wendye R. Robbins and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member | |
MTrap, Inc.
 MTrap, Inc. Miscellaneous Commercial ServicesCommercial Services MTrap, Inc. engages in the development of novel therapeutic devices that interfere with the intense dialogue and crosstalk between the primary tumor and the microenvironment and represent a new disruptive approach to cancer treatment. The company was founded by Maybelle L. Jordan and is headquartered in Huntington, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Pairwise Plants Services
 Pairwise Plants Services Food: Major DiversifiedConsumer Non-Durables Pairwise Plants LLC operates as a agriculture company. The company was founded by Feng Zhang, David Liu and J. Keith Joung and is headquartered in Durham, NC. | Food: Major Diversified | Chairman | |
Auron Therapeutics, Inc.
 Auron Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Auron Therapeutics, Inc. operates as a biotechnology company. It aims to cure cancer by radically changing the paradigm of cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells. The company was founded by Kate Yen, Matt Vander Heiden, Ross Levine, and Eytan Stein and is headquartered in Wellesley, MA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| ELANCO ANIMAL HEALTH INCORPORATED | Biotechnology | Corporate Officer/Principal | |
Redona Therapeutics, Inc.
 Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| MODERNA, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
Vibliome Therapeutics LLC
 Vibliome Therapeutics LLC BiotechnologyHealth Technology Vibliome Therapeutics LLC develops therapeutics for the treatment of cancer, contraception and other indications. The company was founded by Gary Flynn in 2017 and is headquartered in Bozeman, MT. | Biotechnology | Director/Board Member | |
| WEREWOLF THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
Frontier Medicines Corp.
 Frontier Medicines Corp. Pharmaceuticals: MajorHealth Technology Frontier Medicines Corp. develops medicines that redefine the course of debilitating diseases. The company was founded by Chris Varma, Daniel K. Nomura and Roberto Zoncu in 2018 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Civetta Therapeutics LLC
 Civetta Therapeutics LLC Pharmaceuticals: MajorHealth Technology Civetta Therapeutics LLC develops therapeutics for cancers and other diseases. The company was founded by William Sellers and Eric Fischer and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman | |
| NEUROBO PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| LUMOS PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| NUVALENT, INC. | Biotechnology | Director/Board Member | |
AlivaMab Discovery Services LLC
 AlivaMab Discovery Services LLC BiotechnologyHealth Technology AlivaMab Discovery Services LLC is a private company that specializes in generating and screening large panels of antibodies to achieve their partners' design goals. AlivaMab Discovery Services is based in San Diego, CA. The company focuses on delivering antibodies that are characterized for function, kinetics, and developability, and engineering for advanced modalities, including multispecifics and cars. The company has experience in antibody drug discovery and development from many of the world's top pharmaceutical companies, including AbbVie, AstraZeneca, Bristol Myers Squibb, Novartis, Pfizer, and Roche/Genentech. The company was founded by John Lippincott, and the CEO is Larry L. Green. | Biotechnology | Director/Board Member | |
| TURMERIC ACQUISITION CORP. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
| CLENE INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Director of Finance/CFO | |
Neomorph, Inc.
 Neomorph, Inc. Pharmaceuticals: MajorHealth Technology Neomorph, Inc. is an American venture-backed biotechnology company that focuses on discovering innovative new medicines against 'undruggable' targets to solve critical problems in human health. The company is headquartered in an undisclosed location and has a key collaboration with the Center for Protein Degradation at the Dana Farber Cancer Institute. Neomorph's team is comprised of industry-leading experts in protein degradation and molecular glues who are committed to advancing the science and technology of molecular glue drug discovery. The company's patient-first, science-driven approach is complemented by its dedication to a supportive and collaborative work environment. Neomorph was founded by Eric Fischer, Philip Chamberlain, Scott A. Armstrong, and Benjamin Ebert, with Philip Chamberlain serving as the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Photys Therapeutics, Inc.
 Photys Therapeutics, Inc. Medical SpecialtiesHealth Technology Photys Therapeutics, Inc. is a company based in Cambridge, MA that was founded by Longwood Fund and Dr. Amit Choudhary of Brigham and Women's Hospital and the Broad Institute of MIT and Harvard. The company is advancing phosphorylation inducing chimeric small molecules (PHICs), a proprietary new class of bifunctional medicines that direct and repair protein phosphorylation to treat a range of diseases including cancer, immune, metabolic, and rare diseases. PHICs enhance the pairing of specific kinases with disease target proteins, inducing precise phosphorylation at native and/or non-native sites, modulating key functions including activation, stabilization, trafficking, localization, phospho-antigen presentation, inactivation, degradation, and interactions of proteins. The company's approach unlocks diverse classes of targets, developing a new class of medicines for precise control of protein function. The company was founded by Amit Choudhary, David Steinberg, Edward Holson, Lizzie Ngo. David Steinberg has been the CEO since incorporation. | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| CARISMA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Kensington Capital Holdings LLC
 Kensington Capital Holdings LLC Investment ManagersFinance Kensington Capital Holdings LLC (Kensington Capital) is a private equity firm founded in 2008 by Alison H.Mosca. The firm is headquartered in Foxboro, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO Director/Board Member |
Statistics
International
| United States | 45 |
| South Korea | 3 |
| France | 2 |
| United Kingdom | 2 |
| China | 2 |
Sectoral
| Health Technology | 27 |
| Finance | 10 |
| Consumer Services | 9 |
| Commercial Services | 4 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 144 |
| Corporate Officer/Principal | 49 |
| Independent Dir/Board Member | 40 |
| President | 30 |
| Chief Executive Officer | 29 |
Most connected contacts
| Insiders | |
|---|---|
| Luke Evnin | 42 |
| Mitchell Finer | 26 |
| Briggs Morrison | 26 |
| Craig Jalbert | 20 |
| Cameron Wheeler | 20 |
| Alon Lazarus | 18 |
| Scott Canute | 17 |
| Douglas Fambrough | 14 |
| Barbara Yanni | 13 |
| Tae-Heum Jeong | 11 |
| Theodore Ashburn | 10 |
| Mary Fenton | 10 |
| John McCabe | 10 |
| Richard J. Wanstall | 9 |
| Stephen Harbin | 9 |
- Stock Market
- Insiders
- Spencer Nam
- Company connections
